Abnormal neurogenesis and cortical growth in congenital heart disease
A research team led by Children’s National Hospital uses a preclinical model to demonstrate that SVZ NSPCs contribute to perinatal corticogenesis and to suggest that restoration of SVZ NSPCs’ neurogenic potential is a candidate therapeutic target for improving cortical growth in CHD. Children's researchers featured in the video include: Vittorio Gallo, Ph.D., Richard Jonas, M.D., Paul Morton, Ph.D. and Nobuyuki Ishibashi, M.D.
Related research article
About the Expert
Vittorio Gallo, Ph.D.
Interim Chief Academic Officer, Children’s National Hospital
Interim Director, Children’s National Research Institute
Director, District of Columbia Intellectual and Developmental Disabilities Research Center (DC-IDDRC)
Nobuyuki Ishibashi, M.D.
Foglia-Hills Professor of Pediatric Cardiac Research
Director of Cardiac Surgery Research Laboratory
Principal Investigator
Richard Jonas, MD
Emeritus Chief, Cardiac Surgery
Senior Investigator, Center for Neuroscience Research